Efficacy and safety of transcranial direct current stimulation for obsessive-compulsive patients
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0004940
- Lead Sponsor
- Hallym University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 60
(1) Men and women aged 19 to under 65
(2) Patients who meet the criteria for Obsessive-compulsive disorder diagnosis (Diagnosis is based on DSM-IV)
(3) Patients who meet the criteria for diagnosing depression with sub-depressive depression
(Sub-depressive depressive disorder does not correspond to the diagnosis of major depressive disorder and depressive disorder, but must include one key symptom such as depression or decreased interest, and two or more symptoms out of the nine major depressive diagnosis criteria Diagnosis when more than half of them last for more than 2 weeks)
(4) A person who can read and understand the subject's explanation and consent form, and who is capable of language proficiency at a level capable of answering the questionnaire.
(5) A person who voluntarily decides to participate in this clinical trial and agrees in writing to the subject autonomous agreement, who can participate in the entire period of the clinical trial.
(1) A person who has been diagnosed with AXIS I except for depressive disorder and obsessive-compulsive disorder (all diagnoses are based on DSM-IV.)
(2) Those who have been diagnosed with alcohol abuse and alcohol dependence
(3) Those who have been diagnosed with bipolar or psychotic disorders
(4) A person who attempted suicide within 6 months of the screening date
(5) Those who are rated as 6 or higher on suicidal tendency (specific judgment on suicidal accidents ~, separated from No. 4)
(6) Those who are judged to have problems with EEG and electrode attachment due to scalp deformities, inflammatory reactions, or other dermatological problems
(7) A person deemed to have other reasons for prohibiting the use of the transcranial direct current stimulator (eg, when a metal plate is inserted in the head)
(8) Those with a history of epilepsy and family history
(9) Persons with clinically serious disabilities in the cardiovascular system, digestive system, respiratory system, endocrine system, and central nervous system
(10) Participants in other clinical trials within 30 days of the screening date
(11) Women who may be pregnant, who do not consent to contraception in a medically acceptable manner until 24 weeks after the application of the clinical trial device in this clinical trial.
(Medical-acceptable methods of contraception: condoms, contraception if continued for at least 3 months, injectable or implantable contraceptives, intrauterine contraceptives, etc.)
(12) Pregnant or lactating women
(13) In addition to the above, the person in charge of the study or the person in charge who has clinical significance that is considered medically unsuitable for this study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method functional Near-Infrared Spectroscopy, Electroencephalogy
- Secondary Outcome Measures
Name Time Method Self report questionaire